TinaMarinaPassalarisMD

Oncology • Corvallis, OR

Physician

Join to view full profile

Dr. Passalaris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Passalaris' full profile

Already have an account?

Office
501 NW Elks Dr
Corvallis, OR 97330
Phone+1 541-768-4950

Fax+1 541-768-9377

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1995 - 1998
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1992 - 1995
New York University School of MedicineClass of 1992

Certifications & Licensure

OR State Medical License 2016 - 2025
WA State Medical License 1995 - 2025
HI State Medical License 2018 - 2022
AK State Medical License 2014 - 2021
NJ State Medical License 2011 - 2015
NY State Medical License 1994 - 2014
ME State Medical License Active through 2012
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

97 citations
The G(2) checkpoint is maintained by redundant pathways.
Tina M. Passalaris, Jennifer A. Benanti, Lindy Gewin, Tohru Kiyono, Denise A. Galloway
Molecular and Cellular Biology. 1999-09-01
9 citations
Description of the first two seemingly unrelated Greek Cypriot families with a common C618R RET proto-oncogene mutation.
Vassos Neocleous, Tina Passalaris, Elena Spanou, Petros Kitsios, Nicos Skordis
Genetic Testing. 2004-09-29
73 citations
Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation.
John Langenfeld, Fulvio Lonardo, Hiroaki Kiyokawa, Tina Passalaris, Myung-Ju Ahn
Oncogene. 1996-11-07

Press Mentions

Locum Tenens — Keeping Healthcare AccessibleNovember 9th, 2016

Grant Support

G2 Checkpoint Integrity In P53 Depleted CellsNational Cancer Institute1999–2000